Yamatane Corporation ( ($JP:9305) ) has shared an update. Yamatane Corporation has decided to continue its restricted stock remuneration plan for ...

Hims & Hers Health shares plunged nearly 13% as investors reacted to CEO Andrew Dudum's $11 million stock sale. Learn more about the impact and implications of this significant transaction.